Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CA 4. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116768904B reveals high-yield chiral synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with superior enantioselectivity.
Novel Ni-catalyzed asymmetric synthesis offers high yield and enantioselectivity for pharmaceutical intermediates, ensuring supply chain stability.
Novel preparation method for ADZ6140 reducing side reactions. High purity intermediates. Cost-effective manufacturing for global supply chains.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with reduced costs and enhanced supply chain reliability for global pharmaceutical partners.
Patent CN114751883B reveals efficient Pd-catalyzed carbonylation. Delivers high-purity benzofuran-3-carboxamide with supply chain stability.
Patent CN111675662A reveals a novel iron-catalyzed route for high-purity quinazolinone intermediates. Discover cost-effective manufacturing and scalable supply solutions.
Novel FeCl3-catalyzed route for 2-CF3 quinazolinones. High yield, scalable process for API intermediates. Cost-effective manufacturing solution.
Novel FeCl3-catalyzed route offers high yields and scalability for drug discovery, reducing costs in API manufacturing significantly.
Patent CN117247370A enables room-temperature thioflavonoid synthesis using CO2. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Advanced palladium-catalyzed synthesis for benzofuran-3-carboxamide. Delivers high-purity pharmaceutical intermediates with optimized supply chain reliability and cost efficiency.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN111675662B reveals a scalable iron-catalyzed route to 2-trifluoromethyl quinazolinones, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN113087714B reveals a novel Rh(II)-catalyzed N-H insertion route for axial chiral indolocarbazoles, offering high enantioselectivity and scalable pharmaceutical intermediate manufacturing.
Efficient bromination and decarboxylation route for high-purity pyrrole acid anhydrides. Reduces steps and improves yield for reliable supply chain.
Novel one-pot method for 2-trifluoromethyl quinazolinones using nitro compounds. High yield, scalable process for pharmaceutical intermediates.
Patent CN114751883B reveals efficient palladium-catalyzed carbonylation. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production. Scalable process offers significant cost and supply chain advantages for global pharmaceutical partners.
Novel copper-catalyzed route avoids explosive azides, offering safer cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115260188A details a novel cobalt-catalyzed carbonylation route for tetrahydro-beta-carbolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN113880724A reveals a cost-effective Knoevenagel-based route for 3-(2-aminophenyl)-2-acrylate, offering high purity and scalable manufacturing for global API supply chains.